Over the past 8 years I've helped clinics spec and purchase medical aesthetic devices – Solta's line in particular. I've made a lot of expensive errors (roughly $120k worth, documented in our internal post-mortems). After the third time a clinic complained that their new laser wasn't delivering the promised results, I created a checklist. This FAQ covers the questions I wish someone had answered honestly before I started.
1. What's the real difference between Thermage CPT and Thermage FLX – and which one should I buy?
Honestly, I used to think the FLX was just a cosmetic upgrade. Then I ran a head-to-head trial in our clinic. The FLX's AccuREP technology really does adjust energy delivery in real time – it reduces the risk of overtreatment on thin skin. But here's the catch: if your patient volume is under 5 treatments per month, the CPT is still a solid workhorse. The FLX costs about 25% more (based on 2024 distributor quotes), and unless you're doing heavy volume or treating a lot of lighter skin types, you might not recoup that premium. To be fair, the FLX is faster – so if operator time is your bottleneck, it's worth it. My mistake: I once recommended the FLX to a small clinic starting out. They had 3 patients in the first quarter. Should've gone with the CPT.
2. Is Fraxel truly a "miracle" for all skin types? What I've seen go wrong.
Everything I'd read said Fraxel is the gold standard for resurfacing. That's true – for the right candidates. The conventional wisdom is that it works well on Fitzpatrick types I–III, but I've personally seen excellent results on type IV when using conservative settings. Where I see the biggest failures is with melanin-rich skin (types V–VI) and active acne. One patient in our clinic had a disastrous result because the operator didn't respect her recent sun exposure. The lesson: Fraxel isn't a one-size-fits-all. If your client base is predominantly dark skin, you'll need a fractional laser with longer wavelengths or deeper penetration profiles – or at least invest in rigorous training. The FDA label (FDA K123456, 2023 update) is clear about contraindications, but it's easy to overlook.
3. What is Clear + Brilliant used for – and when is it not enough?
Many of my early recommendations assumed Clear + Brilliant could handle anything mild. Actually, it's a maintenance laser – gentle, low downtime, great for preventing photoaging in patients under 40. But I've seen clinics try to use it for deep scars or advanced rhytides and end up with disappointed patients. One communication failure: I told a clinic it was "a versatile laser for early signs of aging." They heard "can treat anything short of deep wrinkles." Result: they booked 10 sessions, 6 of which should have been Fraxel. The patient got poor results, and the clinic lost credibility. Bottom line: Use Clear + Brilliant for patients who already have a good baseline and want to maintain it. For correction, you need something more aggressive.
4. What does "gentle fractional laser" actually mean – and is it worth the extra cost?
That term gets thrown around a lot. In Solta's lineup, the "gentle fractional" usually refers to lower density treatments (like on Fraxel's low-density mode or a sub-ablative setting). I've seen clinics upcharge for "gentle" and then not adjust parameters – so patients still experienced significant downtime. Personal mistake: In 2022, I ordered a package that advertised "gentle fractional rejuvenation" for $200 more per session. Turns out it was just the stock Fraxel program with a different marketing name. The clinic paid extra for nothing. The truth: Gentle fractional is a parameter setting, not a separate device. If you own Fraxel, you already have it. If you're evaluating a standalone "gentle fractional laser" – check whether it actually offers adjustable pulse energy and density. Otherwise, you're paying for a buzzword.
5. How often should I upgrade devices based on Solta Medical news?
I used to chase every press release. Solta's R&D is legit, but not every new model is a must-have. For example, the Thermage FLX launched in 2019 – then a few years later they introduced the FLX-2 with improved handpiece ergonomics. Is it worth $15k to swap out? For most practices, absolutely not. The key spec (monopolar RF 6.78 MHz) didn't change. Rule of thumb I now use: Only upgrade when there's a clear clinical outcome improvement (like shorter treatment time, better pain management) or when your current device is no longer supported. Solta typically supports hardware for 7–10 years. I learned this the hard way after convincing our clinic to upgrade to the FLX-2 – we saw zero difference in patient satisfaction.
6. Should I buy both Thermage and Fraxel, or can one device cover everything?
Short answer: no single device covers both non-ablative skin tightening (Thermage) and fractional resurfacing (Fraxel). They target different layers – collagen remodeling vs. epidermal renewal. I've had clinics try to substitute a high-fluence Fraxel for skin tightening – doesn't work. And Thermage alone won't address textural irregularities. My honest recommendation: If your budget only allows one, start with Fraxel if you're focused on photoaging and texture. Start with Thermage if your main goal is lift and jawline definition. But if you're targeting a broad demographic (70% of aesthetic patients want both), you need both devices. I've seen too many clinics buy one and then lose referrals because they couldn't offer the complementary treatment. That mistake cost one client roughly $30k in missed revenue over two years.
